Would Hunters Take a Lyme Disease Vaccine? We Asked
It’s tick season, possibly the worst in a decade. More and more Americans are being…
Would Hunters Take a Lyme Disease Vaccine? We Asked
It’s tick season, possibly the worst in a decade. More and more Americans are being exposed to these parasites as climate change expands the range where they can survive. That means more people are also exposed to the bevy of health conditions they can cause, such as Rocky Mountain spotted fever, the alpha-gal-triggered red meat…
He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
Benjamin Pinckney, 46, has dreamed of becoming a physician assistant since just after his 20th birthday. He had been targeted by a drive-by shooter in Jacksonville, Florida, and hospitalized with two gunshot wounds. During his weeklong hospitalization, he said, a physician assistant changed the course of his life by visiting his hospital bed each day…
These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
WINSTON-SALEM, N.C. — Some issues, like immigration or student loans, are too divisive to unite Trinity Moravian Church. “We’ve got quite a spread of political beliefs,” said the Rev. John Jackman, who leads this 114-year-old red-brick church near Winston-Salem’s old textile mills. Conservative Republicans sit with liberal Democrats. Supporters of President Donald Trump mix with…
KFF Tracking Poll on Health Information and Trust: Update on Common Vaccine Myths
This poll looks at exposure to and belief in several vaccine myths and finds that people without a trusted health care provider, and those who regularly use social media or AI for health information, are generally more likely than others to belief the false claims. It also analyzes belief across vaccine myths, showing the share…
AI: Show Me the Outcomes
Chip talks with Dr. Toyin Ajayi, co-founder and CEO of Cityblock Health, which delivers value-based care to more than 100,000 Medicaid and dual-eligible members across ten states, many of them people of color managing chronic conditions. [AB1.1][AB1.2][MR1.3][AB1.4]Ajayi makes a pointed case: Roughly 60 percent of health care AI investment goes to billing, coding, and risk…
Poll: People Without a Trusted Health Care Provider Are More Likely to Endorse Vaccine Myths, As Are Those Who Often Use Social Media or AI for Health Information
People who don’t have a trusted health care provider are more likely than people with one to believe or lean toward believing several common myths about vaccines, a new KFF Tracking Poll on Health Information and Trust reveals.
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
June has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, the American Medical Association, CMS and R1 RCM named new executives. There were also layoffs at organizations including ADC Therapeutics, Equip and UPMC. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on…
4 Notable Health Tech Funding Announcements in June
Health tech companies made several major funding announcements in June. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in June appeared first on MedCity News.
Who participates in the clinical trials of FDA-approved drugs?
The answer is provided by FDA’s 2025 Drug Trials Snapshots Summary Report. The report covers 46 novel drug approvals and roughly 26,000 participants across pivotal trials, organized by therapeutic area rather than a single aggregate narrative. Half (23 out of 46) of these approvals were for the treatment of rare or orphan diseases (i.e., diseases…
Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better
Ipsen is acquiring Kartos Therapeutics to get navtemadlin, which has reached Phase 3 testing in the blood cancer myelofibrosis. The Kartos oral small molecule takes a novel approach to restoring the function of p53, a tumor-suppressing protein. The post Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better appeared first…
